DGCI approved drug trial of phytopharmaceutical, favipiravir
The Drug Controller General of India has approved the clinical trials of phytopharmaceutical and favipiravir for the Council for Scientific and Industrial Research (CSIR). With this approval, CSIR will begin the clinical trial of two drugs to treat COVID-19 patients. The drug trial will begin soon. CSIR has already been working with pharmaceutical companies for […]
DGCI approved drug trial of phytopharmaceutical, favipiravir Read More »










